Affiliation:
1. University Clinic for Gynaecology and Obstetrics, University Medical Centre Maribor, Ljubljanska 5, 2000 Maribor, Slovenia
2. Department of Pathology and Cytology, General Hospital Celje, Oblakova 5, 3000 Celje, Slovenia
Abstract
Cervical cancer screening has enabled a decrease in the incidence and mortality of cervical cancer. Various screening modalities have been studied to date. In many countries, screening is still based on cervical cytology, where cervical cells obtained either on glass or in a liquid medium are examined under a microscope. However, the fact that the vast majority of cervical cancers are a result of persistent infection with high-risk human papillomaviruses (hr-HPV) has led to the implementation of primary HPV screening in many countries. Taking into consideration the fact that the majority of HPV infections are transient and do not cause cervical precancer, effective triage methods are needed to prevent an increase in colposcopy referrals. Among these, the most extensively investigated are HPV genotyping, HPV methylation, and p16/Ki67 dual staining. In this manuscript, we briefly summarize the current knowledge regarding different screening strategies for the prevention of cervical cancer, with a focus on p16/Ki67 dual staining. In addition, we provide an explanation regarding the rationale for the use of various screening modalities based on the molecular biology of cervical cancer and cervical precancerous lesions.
Subject
Microbiology (medical),Molecular Biology,General Medicine,Microbiology
Reference102 articles.
1. Primary HPV-based cervical cancer screening in Europe: Implementation status, challenges, and future plans;Maver;Clin. Microbiol. Infect.,2020
2. Ayhan, A., Reed, N., Gultekin, M., and Dursun, P. (2016). Textbook of Gynaecological Oncology, European Society of Gynaecological Oncology. [2nd ed.].
3. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: A subanalysis of the ATHENA study;Castle;Lancet Oncol.,2011
4. Evaluation of 14 triage strategies for HPV DNA-positive women in population-based cervical screening;Rijkaart;Int. J. Cancer,2012
5. Primary hrHPV DNA testing in cervical cancer screening: How to manage screen-positive women? A POBASCAM trial substudy;Dijkstra;Cancer Epidemiol. Biomark. Prev.,2014
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献